Table 4 Vascular parameters among participants using blood pressure-lowering medications
Unadjusted | Adjusted for age and sex | Adjusted for age, sex and, mean arterial pressurea | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CH | WUCH | MUCH | SUCH | CH | WUCH | MUCH | SUCH | CH | WUCH | MUCH | SUCH | |
(n = 74) | (n = 44) | (n = 22) | (n = 98) | (n = 74) | (n = 44) | (n = 22) | (n = 98) | (n = 74) | (n = 44) | (n = 22) | (n = 98) | |
Office PWV, m/s | 7.68 ± 1.71 | 8.70 ± 2.32* | 6.92 ± 1.37† | 8.21 ± 1.84* | 7.43 ± 0.08 | 8.28 ± 0.11* | 7.61 ± 0.15† | 8.43 ± 0.07*‡ | 7.81 ± 0.09 | 8.19 ± 0.10* | 8.02 ± 0.15 | 8.10 ± 0.08* |
24 h PWV, m/s | 7.45 ± 1.70 | 7.94 ± 2.09 | 7.00 ± 1.38 | 7.72 ± 1.70 | 7.21 ± 0.07 | 7.54 ± 0.09* | 7.64 ± 0.13* | 7.93 ± 0.06*†‡ | 7.45 ± 0.08 | 7.69 ± 0.09* | 7.63 ± 0.12 | 7.69 ± 0.08 |
Daytime PWV, m/s | 7.50 ± 1.65 | 7.99 ± 2.06 | 7.01 ± 1.35 | 7.80 ± 1.69 | 7.26 ± 0.07 | 7.60 ± 0.09* | 7.65 ± 0.12* | 8.01 ± 0.06*†‡ | 7.47 ± 0.08 | 7.73 ± 0.09* | 7.66 ± 0.12 | 7.79 ± 0.08* |
Nighttime PWV, m/s | 7.37 ± 1.77 | 7.79 ± 2.12 | 6.94 ± 1.43 | 7.59 ± 1.74 | 7.13 ± 0.08 | 7.39 ± 0.10* | 7.60 ± 0.14* | 7.81 ± 0.07*† | 7.38 ± 0.08 | 7.55 ± 0.10 | 7.54 ± 0.13 | 7.56 ± 0.07 |
Office AIx | 27.9 ± 11.5 | 28.4 ± 13.6 | 30.1 ± 9.2 | 28.4 ± 10.4 | 26.7 ± 1.2 | 26.7 ± 1.6 | 32.6 ± 2.2*† | 29.5 ± 1.1 | 28.9 ± 1.5 | 26.1 ± 1.6 | 35.0 ± 2.4*†‡ | 27.6 ± 1.3 |
24 h AIx | 26.1 ± 8.3 | 26.1 ± 9.0 | 23.5 ± 6.4 | 26.0 ± 9.0 | 24.5 ± 0.7 | 23.8 ± 0.9 | 27.0 ± 1.3 | 27.5 ± 0.6*† | 26.0 ± 0.9 | 24.7 ± 1.0 | 26.9 ± 1.3 | 26.0 ± 0.9 |
Daytime AIx | 26.2 ± 7.6 | 26.1 ± 8.4 | 24.3 ± 6.2 | 27.1 ± 8.4 | 24.9 ± 0.7 | 24.1 ± 0.9 | 27.2 ± 1.3 | 28.3 ± 0.6*† | 26.3 ± 0.9 | 25.0 ± 1.0 | 27.2 ± 1.3 | 26.8 ± 0.8 |
Nighttime AIx | 26.0 ± 11.6 | 26.6 ± 10.6 | 22.7 ± 10.3 | 24.1 ± 11.6 | 23.9 ± 1.0 | 23.7 ± 1.3 | 27.1 ± 1.9 | 25.9 ± 0.9 | 25.5 ± 1.1 | 24.7 ± 1.3 | 26.8 ± 1.8 | 24.4 ± 1.0 |